ACPs in Severe PAD/CLI by Direct Intramuscular Injection

NCT00523731 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Arterial Disease
Critical Limb Ischemia

Interventions

PROCEDURE: Angiogenic Cell Precursors (ACPs) or Vescell TM

Sponsor

TheraVitae Ltd.